Adar Poonawalla
Recent Highlights
All Stories for Adar Poonawalla
Why Serum Institute’s qHPV vaccine, India’s first against cervical cancer, is a game-changer
Fp Explainers •Cervavac, India’s first vaccine to fight cervical cancer, will be launched today. This vaccine will be both affordable and accessible for millions of women vulnerable to the disease
Monkeypox won't be pandemic as big as COVID, we're working on vaccine: Adar Poonawalla
Fp Staff •The SII CEO was honoured with the 'Amrit Ratna Samman' at the News18 India event in Delhi on Tuesday
SII might have to destroy 200 million COVID-19 vaccines due to oversupply, says Adar Poonawalla
Shereenbhan123 •The Serum Institute of India’s chief executive is advocating a global pandemic treaty and proposing that next time there is a framework for leaders to work with rather than having to negotiate
Invest in making Tesla cars in India, Adar Poonawalla to Elon Musk
Fp Staff •Elon Musk, the world's richest individual, recently struck a deal to buy Twitter for $44 billion
SII's COVID-19 vaccine Covovax now available for children in India: Adar Poonawalla
•SII's CEO Adar Poonawalla said the vaccine is in line with Prime Minister Narendra Modi's 'vision of providing yet another vaccine to protect our children'
Adar Poonawalla warns against return to business-as-usual approach
•He pointed out that there is rising vaccine fatigue among the public as the main reason for the low off-take of the vaccines even after the firm has massively slashed the price from Rs 600 to Rs 225 a dose
COVID-19: Indian vaccines better than Pfizer, Moderna, says Adar Poonawalla
•The COVID-19 vaccines which have been made in India are providing more protection against the disease than mRNA vaccines like Pfizer and Moderna, said Adar Poonawalla
COVID-19: Indian vaccines sold in Europe for first time, says Adar Poonawalla; lauds Centre's work during pandemic
Fp Staff •On 9 April, Poonawalla said in a tweet that SII had decided to revise the price of Covishield vaccine for private hospitals from Rs 600 to Rs 225 per dose
Serum Institute seeks emergency use authorisation for its rBCG tuberculosis vaccine
•India's TB immunisation programme currently offers BCG vaccination at birth or as early as possible till one year of age
Why India's vaccine advisory body recommends reducing second-dose gap for Covishield
Fp Explainers •The National Technical Advisory Group on Immunisation has recommended that the gap between the first and second dose of Covishield should be reduced to eight to 16 weeks, from the current gap of 12 to 16